Details for New Drug Application (NDA): 022103
✉ Email this page to a colleague
The generic ingredient in SANCTURA XR is trospium chloride. There are sixteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the trospium chloride profile page.
Summary for 022103
Tradename: | SANCTURA XR |
Applicant: | Allergan |
Ingredient: | trospium chloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Aug 3, 2007 | TE: | RLD: | Yes |
Complete Access Available with Subscription